company background image
524212 logo

Wanbury BSE:524212 Stock Report

Last Price

₹259.95

Market Cap

₹8.4b

7D

7.1%

1Y

195.4%

Updated

08 Nov, 2024

Data

Company Financials

524212 Stock Overview

Manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally.

524212 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health2/6
Dividends0/6

Wanbury Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Wanbury
Historical stock prices
Current Share Price₹259.95
52 Week High₹291.00
52 Week Low₹88.00
Beta0.53
11 Month Change3.65%
3 Month Change28.85%
1 Year Change195.40%
33 Year Change227.60%
5 Year Change1,763.44%
Change since IPO39.50%

Recent News & Updates

Recent updates

Shareholder Returns

524212IN PharmaceuticalsIN Market
7D7.1%-0.6%0.8%
1Y195.4%51.3%36.2%

Return vs Industry: 524212 exceeded the Indian Pharmaceuticals industry which returned 51.3% over the past year.

Return vs Market: 524212 exceeded the Indian Market which returned 36.2% over the past year.

Price Volatility

Is 524212's price volatile compared to industry and market?
524212 volatility
524212 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524212 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 524212's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19881,491Mohan Rayanawww.wanbury.com

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas.

Wanbury Limited Fundamentals Summary

How do Wanbury's earnings and revenue compare to its market cap?
524212 fundamental statistics
Market cap₹8.41b
Earnings (TTM)₹523.05m
Revenue (TTM)₹5.60b

16.3x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524212 income statement (TTM)
Revenue₹5.60b
Cost of Revenue₹2.84b
Gross Profit₹2.77b
Other Expenses₹2.24b
Earnings₹523.05m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 13, 2024

Earnings per share (EPS)15.97
Gross Margin49.35%
Net Profit Margin9.33%
Debt/Equity Ratio416.9%

How did 524212 perform over the long term?

See historical performance and comparison